The FDA has walked away from a 2010 rule that would have forced drug makers to disclose fabricated data to regulators.
As Bloomberg Law reported last week, the FDA has withdrawn the proposed rule, “Reporting Information Regarding Falsification of Data,” which would Continue reading As China cracks down on faked drug trial data, US FDA abandons disclosure rule
Papers are corrected for lots of different reasons. In this guest post, Anita Bandrowski, who leads an initiative designed to help researchers identify their reagents correctly, describes one unusual reason for a correction — and explains what researchers can learn from the episode.
Last December, Tianyi Wang and her colleagues published a very interesting paper in Cell Metabolism on the potential link between a gene called JAK/STAT3 and breast cancer. It turns out that breast cancers become resistant to chemotherapy via a pathway that involves JAK/STAT3, and blocking this pathway can re-sensitize the tumor to chemotherapy.
But six months later, they corrected the paper — because of typos in the catalog numbers they’d used. Continue reading How a typo in a catalog number led to the correction of a scientific paper — and what we can learn from that
A month after a journalism investigation that led to resignations and turmoil at Memorial Sloan Kettering Cancer Center in New York, researchers including a Sloan Kettering scientist have quietly corrected at least two papers to add disclosures of financial conflicts of interest.
The two corrections, in Chemistry of Materials, are dated October 8, 2018 and read: Continue reading In wake of media scrutiny, Sloan Kettering author adds financial disclosures
A researcher at the University of Kentucky who studies the cancer risks of toxic chemicals has retracted three papers.
All of the retraction notices, which appear in the Journal of Biological Chemistry, refer to some kind of image duplication. The papers were originally published between 2014 and 2017, with the 2014 paper cited 39 times, according to Clarivate Analytics’ Web of Science.
The address was supposed to be a triumphant inaugural speech.
On Friday, Leonid Eidelman, the incoming president of the World Medical Association (WMA), made up of representatives from national medical associations, stood up in front of the group’s members in Reykjavik, Iceland, and told them it was a great honor to become their leader.
The trouble was, his speech had lifted passages from various sources — including remarks one of his predecessors had given in 2014. The following morning, members of the Canadian Medical Association (CMA) — including Chris Simpson, who had delivered the original 2014 speech — made a motion for Eidelman to resign. When that failed, the CMA said it was leaving the WMA.
CMA president Gigi Osler said in a statement: Continue reading Canadian Medical Association leaves international group after president plagiarizes past president’s speech
Kathy Partin, who served as director of the U.S. Office of Research Integrity (ORI) for just under two years until being removed from the post late in 2017, has a new position at the U.S. National Institutes of Health (NIH), Retraction Watch has learned.
As of yesterday (Sept. 30), Partin is intramural research integrity officer at the NIH. She replaces Melissa Colbert, who will be retiring. Continue reading Former director of U.S. research watchdog agency moves to NIH
A toxicology journal has issued an expression of concern for a group of papers about the controversial herbicide glyphosate after concluding that some of the authors didn’t adequately disclose their ties to the maker of the product.
At issue are five articles that appeared in a 2016 supplement to Critical Reviews in Toxicology, a Taylor & Francis title, about the chemical, the active ingredient in Monsanto’s blockbuster weed-killer Roundup. Although the authors of the articles don’t overlap perfectly, Keith Solomon, of the University of Guelph, in Canada, appears on three of the articles; Gary Williams, of New York Medical College, appears on three as well.
Williams was caught up in a ghost-writing scandal after court documents revealed that he had put his name on a published paper written by Monsanto employees. Solomon served on a panel funded by Monsanto that undercut the conclusions of a report from the World Health Organization that glyphosate is probably cancerous to people.
According to the expression of concern, which was first reported by Bloomberg today: Continue reading Journal flags papers, saying authors didn’t adequately disclose ties to Monsanto
A journal that retracted three papers earlier this year because of concerns that one of the authors had asked conference presenters to cite them has republished the articles, saying that it has “inconclusive evidence of improper behavior.”
In February, we reported that the Journal of Vibroengineering had retracted three papers by Magd Abdel Wahab, of Ghent University in Belgium. Wahab had chaired a recent conference, and as we reported then, almost three-quarters of papers that cited Wahab’s three papers originated from the conference. Journal editor Minvydas Ragulskis told us that was “large enough to assume a high probability for citation manipulation.”
At the time, Wahab told us the papers would be republished. And it turns that they were, not long after our original post. There is no explanation on the papers themselves, just a “Republished Paper” in front of the three titles, and an editorial note that is not linked, as best we can tell, from any of the papers.
Along with the citation data the investigation was based on, that note explains that: Continue reading Journal reverses retractions, says apparent citation manipulation was “an innocent and honest mistake”
A cancer researcher who went to court — unsuccessfully — claiming that commenters on PubPeer had cost him a new job has just lost another 12 papers.
The twelve now-retracted papers by Fazlul Sarkar and colleagues — as well as another by Sarkar that is now subject to an editor’s note — all appeared in Cancer Research, which made for a long table of contents in its September 15 issue. Continue reading Researcher who once tried to sue critics has another dozen papers retracted
H. Gilbert Welch, a leading researcher in the field of health policy, has resigned from his faculty post at Dartmouth College after the institution concluded that he had plagiarized from a colleague in a 2016 paper.
As we reported in STAT earlier this summer, a Dartmouth committee found that Welch had misused a figure from a colleague, Samir Soneji, who had provided him the data after a 2015 presentation. At the time, Soneji had requested that he be part of any paper that would include the data — but Welch said he had no intention of publishing it. However, the information appeared in a 2016 article in the New England Journal of Medicine, which has declined to retract or even correct the paper. Continue reading High-profile health policy researcher Gilbert Welch out at Dartmouth after plagiarism charge